Stock listing

SLZ Stock Price, News, Filings & Events — Enveric Biosciences, Inc.

Selected listing: SLZ · SWB · EUR · DE

This page tracks Enveric Biosciences, Inc.'s SLZ:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLZ:SWB. SLZ:SWB is the stock-level entry point for investors researching Enveric Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Enveric Biosciences, Inc. (Ticker: ENVB) is a public company based in the United States, focusing on the development of innovative therapies. With a market capitalization of approximately $4.75 million, Enveric is dedicated to advancing its research in the biosciences sector. The company aims to address unmet medical needs through its specialized approach.

SLZ:SWBEURDEUpdated August 31, 2026
Enveric Biosciences, Inc. logo
Ticker
SLZ:SWB
Asset type
Stock
Market cap
$6.1M
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
SWB
Currency
EUR

Enveric Biosciences, Inc. SLZ:SWB stock context

This page tracks Enveric Biosciences, Inc.'s SLZ:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLZ:SWB. SLZ:SWB is the stock-level entry point for investors researching Enveric Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Enveric Biosciences, Inc. (Ticker: ENVB) is a public company based in the United States, focusing on the development of innovative therapies. With a market capitalization of approximately $4.75 million, Enveric is dedicated to advancing its research in the biosciences sector. The company aims to address unmet medical needs through its specialized approach.

Latest news from Enveric Biosciences, Inc.

All Enveric Biosciences, Inc. news →

Research Enveric Biosciences, Inc.

Alternate listings